Betacellulin regulates hair follicle development and hair cycle induction and enhances angiogenesis in wounded skin.

[1]  A. Pollins,et al.  Modulation of porcine wound repair with a transfected ErbB3 gene and relevant EGF-like ligands. , 2007, The Journal of investigative dermatology.

[2]  K. Jang,et al.  Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis. , 2006, Human pathology.

[3]  E. Birgitte Lane,et al.  New consensus nomenclature for mammalian keratins , 2006, The Journal of cell biology.

[4]  A. Citri,et al.  EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.

[5]  J. Voorhees,et al.  Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. , 2006, The Journal of investigative dermatology.

[6]  R. Wanke,et al.  Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. , 2005, Endocrinology.

[7]  S. Werner,et al.  Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. , 2005, The American journal of pathology.

[8]  E. Mekada,et al.  Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing , 2005, Journal of Cell Science.

[9]  A. Citri,et al.  Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity* , 2005, Journal of Biological Chemistry.

[10]  S. Cross,et al.  Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor , 2004, Mammalian Genome.

[11]  M. Pittelkow,et al.  Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early‐onset, psoriasis‐like skin pathology: Expression of amphiregulin in the basal epidermis is also associated with synovitis , 2004, Experimental dermatology.

[12]  Geoffrey C Gurtner,et al.  Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. , 2004, The American journal of pathology.

[13]  G. Weskamp,et al.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.

[14]  N. Hynes,et al.  ErbB receptors: directing key signaling networks throughout life. , 2004, Annual review of pharmacology and toxicology.

[15]  S. Chan,et al.  Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle* , 2003, Journal of Biological Chemistry.

[16]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[17]  R. Underwood,et al.  Proliferation–differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes , 2003, Archives of Dermatological Research.

[18]  Robert J Coffey,et al.  EGF receptor ligands. , 2003, Experimental cell research.

[19]  S. Werner,et al.  Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  C. Cho,et al.  Betacellulin induces angiogenesis through activation of mitogen‐activated protein kinase and phosphatidylinositol 3’‐kinase in endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  C. Dinney,et al.  Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  Elaine Fuchs,et al.  Getting under the skin of epidermal morphogenesis , 2002, Nature Reviews Genetics.

[23]  P. A. Harding,et al.  Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. , 2002, The Journal of burn care & rehabilitation.

[24]  M. Pittelkow,et al.  Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation. , 2001, Experimental cell research.

[25]  Injoong Kim,et al.  Wound epithelialization deficits in the transforming growth factor‐α knockout mouse , 2001 .

[26]  R Paus,et al.  A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. , 2001, The Journal of investigative dermatology.

[27]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[28]  R. Timpl,et al.  The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Y. Matsuzawa,et al.  Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound Healing , 2000, The Journal of cell biology.

[30]  A. J. Dunbar,et al.  Structure-function and biological role of betacellulin. , 2000, The international journal of biochemistry & cell biology.

[31]  Fiona M. Watt,et al.  The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development , 2000, Cell.

[32]  S. Yuspa,et al.  The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. , 2000, Cancer research.

[33]  D B Evans,et al.  Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  D. Roop,et al.  Transgenic coexpression of v‐Ha‐ras and transforming growth factor α increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c‐Ha‐ras activation , 2000, Molecular carcinogenesis.

[35]  K. Sayama,et al.  Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes* , 2000, The Journal of Biological Chemistry.

[36]  D. Roop,et al.  12‐O‐tetradecanoylphorbol‐13‐acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor‐α and v‐fos: acceleration of autonomous papilloma formation and malignant conversion via c‐Ha‐ras activation , 1999, Molecular carcinogenesis.

[37]  A. Alonso,et al.  EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT. , 1999, Experimental cell research.

[38]  R Paus,et al.  A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. , 1999, The Journal of investigative dermatology.

[39]  L. Hudson,et al.  Contributions of the epidermal growth factor receptor to keratinocyte motility , 1998, Microscopy research and technique.

[40]  James T. Elder,et al.  Retinoid regulation of heparin‐binding EGF‐like growth factor gene expression in human keratinocytes and skin * , 1998, Experimental dermatology.

[41]  M. Pittelkow,et al.  Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. , 1998, The Journal of investigative dermatology.

[42]  K. Kiguchi,et al.  Altered expression of epidermal growth factor receptor ligands in tumor promoter–treated mouse epidermis and in primary mouse skin tumors induced by an initiation‐promotion protocol , 1998, Molecular carcinogenesis.

[43]  M. Pittelkow,et al.  EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. , 1997, The Journal of investigative dermatology.

[44]  J. Brown,et al.  Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. , 1997, The Journal of clinical investigation.

[45]  D. Riethmacher,et al.  Severe neuropathies in mice with targeted mutations in the ErbB3 receptor , 1997, Nature.

[46]  James T. Elder,et al.  Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture. , 1997, The Journal of clinical investigation.

[47]  T. Magnuson,et al.  Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. , 1997, The American journal of pathology.

[48]  J. Ward,et al.  Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor‐α‐induced epidermal growth factor receptor activation but not p53 inactivation , 1997, Molecular carcinogenesis.

[49]  M. Piepkorn,et al.  Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. , 1996, The American Journal of dermatopathology.

[50]  Kuo-Fen Lee,et al.  Requirement for neuregulin receptor erbB2 in neural and cardiac development , 1995, Nature.

[51]  Rüdiger Klein,et al.  Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.

[52]  A. Ullrich,et al.  Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. , 1995, The EMBO journal.

[53]  M. Klagsbrun,et al.  Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. , 1995, Molecular biology of the cell.

[54]  R. Derynck,et al.  Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor , 1995, Nature.

[55]  E. Wagner,et al.  Strain-dependent epithelial defects in mice lacking the EGF receptor. , 1995, Science.

[56]  K. Herrup,et al.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.

[57]  M. Klagsbrun,et al.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor , 1995, The Journal of cell biology.

[58]  P. Hofschneider,et al.  The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. , 1994, Science.

[59]  S. Werner,et al.  Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. , 1994, The Journal of investigative dermatology.

[60]  H. Asada,et al.  Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. , 1994, The Journal of biological chemistry.

[61]  D. Roop,et al.  Epidermal expression of transforming growth factor‐α in transgenic mice: Induction of spontaneous and 12‐O‐tetradecanoylphorbol‐13‐acetate‐induced papillomas via a mechanism independent of Ha‐ras activation or overexpression , 1994, Molecular carcinogenesis.

[62]  G. Merlino,et al.  Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[63]  G. Plowman,et al.  Amphiregulin‐dependent proliferation of cultured human keratinocytes: Autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin‐like glycosaminoglycans , 1994, Journal of cellular physiology.

[64]  N. Copeland,et al.  The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. , 1994, Genes & development.

[65]  D. Roop,et al.  Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[66]  S. Werner,et al.  Targeted expression of a dominant‐negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. , 1993, The EMBO journal.

[67]  M. Klagsbrun,et al.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[68]  E. Nice,et al.  Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation , 1993, Cell.

[69]  David C. Lee,et al.  TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice , 1993, Cell.

[70]  E. Fuchs,et al.  Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. , 1993, The EMBO journal.

[71]  E. Fuchs,et al.  Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis , 1992, Molecular and cellular biology.

[72]  N. Lemoine,et al.  Expression of the c-erbB-3 protein in normal human adult and fetal tissues. , 1992, Oncogene.

[73]  L. Nanney,et al.  Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. , 1992, The Journal of investigative dermatology.

[74]  E. Fuchs,et al.  Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. , 1991, Genes & development.

[75]  J. Adelman,et al.  A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin , 1991, Molecular and cellular biology.

[76]  L. Nanney,et al.  Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. , 1990, The Journal of investigative dermatology.

[77]  C. Cordon-Cardo,et al.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.

[78]  D. Greenhalgh,et al.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.

[79]  Gary R. Grotendorst,et al.  EGF and TGF‐alpha are potent chemoattractants for endothelial cells and EGF‐like peptides are present at sites of tissue regeneration , 1989, Journal of cellular physiology.

[80]  R. Derynck,et al.  Transmembrane TGF-α precursors activate EGF/TGF-α receptors , 1989, Cell.

[81]  James T. Elder,et al.  Overexpression of transforming growth factor alpha in psoriatic epidermis. , 1989, Science.

[82]  J. Massagué,et al.  The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction , 1989, Cell.

[83]  D. Goeddel,et al.  Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .

[84]  H. Modjtahedi,et al.  Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells , 2004, Clinical & Experimental Metastasis.

[85]  R Paus,et al.  Controls of hair follicle cycling. , 2001, Physiological reviews.

[86]  James T. Elder,et al.  Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. , 2001, Neoplasia.

[87]  G. Besner,et al.  Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. , 1996, The Journal of investigative dermatology.

[88]  Harold L. Moses,et al.  Production and auto-induction of transforming growth factor-α in human keratinocytes , 1987, Nature.

[89]  N. Nomura,et al.  High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. , 1986, Cancer research.